David Gyorki

A survey of surgical management of the sentinel node positive melanoma patient in the post-MSLT2 era

Jennifer S Downs, Suren Subramanian, Michael A Henderson, Elizabeth Paton, Andrew J Spillane, Jon A Mathy, David E Gyorki

Journal article  |  2021  |  JOURNAL OF SURGICAL ONCOLOGY

BACKGROUND: The evidence-based management of melanoma patients with a positive sentinel lymph node biopsy (SLNB) has undergone a d..

Contemporary management of locoregionally advanced melanoma in Australia and New Zealand and the role of adjuvant systemic therapy

B Mark Smithers, Robyn PM Saw, David E Gyorki, Richard CW Martin, Victoria Atkinson, Andrew Haydon, Rachel Roberts-Thomson, John F Thompson

Journal article  |  2021  |  ANZ JOURNAL OF SURGERY

Australia and New Zealand have the highest incidence and mortality rates for melanoma in the world. Local surgery is still the sta..

Letter Regarding Editorial by Samuel Zagarella.

Mark B Faries, Paolo A Ascierto, Christian Blank, Alistair J Cochran, Keith Delman, David Gyorki, John Haanen, Omid Hamid, Dale Han, Giorgos Karakousis, Mohammed Kashani-Sabet, Sancy Leachman, Marc Moncrieff, Elsemieke Plasmeijer, Alessandro Achille Enrico Testori, Alexander Van Akkooi, Sandra Wong, Jonathan S Zager

Journal article  |  2021  |  Am J Dermatopathol

Ptpn2 and KLRG1 regulate the generation and in skin

Katharina Hochheiser, Florian Wiede, Teagan Wagner, David Freestone, Matthias H Enders, Moshe Olshansky, Brendan Russ, Simone Nussing, Emma Bawden, Asolina Braun, Annabell Bachem, Elise Gressier, Robyn McConville, Simone L Park, Claerwen M Jones, Gayle M Davey, David E Gyorki, David Tscharke, Ian A Parish, Stephen Turner, et al.

Journal article  |  2021  |  JOURNAL OF EXPERIMENTAL MEDICINE

Tissue-resident memory T cells (TRM cells) are key elements of tissue immunity. Here, we investigated the role of the regulator of..

ASO Author Reflections: Standardization in the Management of Retroperitoneal Sarcoma Through International Collaboration

David E Gyorki, Christina L Roland

Journal article  |  2021  |  ANNALS OF SURGICAL ONCOLOGY

Second-line immunotherapy in patients with metastatic melanoma Comment

Annie Wong, David E Gyorki

Journal article  |  2021  |  LANCET ONCOLOGY

Knowledge and attitudes of Australian dermatologists towards sentinel lymph node biopsy for melanoma: a mixed methods study.

Andrea L Smith, Caroline G Watts, Samuel Robinson, Helen Schmid, Chris Goumas, Victoria J Mar, John F Thompson, Frances Rapport, undefined Australian Melanoma Centre of Research Excellence Study Group, Anne E Cust

Journal article  |  2021  |  Australas J Dermatol

BACKGROUND/OBJECTIVES: In melanoma management, sentinel lymph node biopsy (SLNB) is used to stage patients and to indicate prognos..

Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group

Carol J Swallow, Dirk C Strauss, Sylvie Bonvalot, Piotr Rutkowski, Anant Desai, Rebecca A Gladdy, Ricardo Gonzalez, David E Gyorki, Mark Fairweather, Winan J van Houdt, Eberhard Stoeckle, Jae Berm Park, Markus Albertsmeier, Carolyn Nessim, Kenneth Cardona, Marco Fiore, Andrew Hayes, Dimitri Tzanis, Jacek Skoczylas, Samuel J Ford, et al.

Journal article  |  2021  |  ANNALS OF SURGICAL ONCOLOGY

BACKGROUND: Retroperitoneal soft tissue sarcomas comprise a heterogeneous group of rare tumors of mesenchymal origin that include ..

Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy trial II (MSLT-2)

Kristy Kummerow Broman, Tasha Hughes, Lesly Dossett, James Sun, Dennis Kirichenko, Michael J Carr, Avinash Sharma, Edmund K Bartlett, Amanda AG Nijhuis, John F Thompson, Tina J Hieken, Lisa Kottschade, Jennifer Downs, David E Gyorki, Emma Stahlie, Alexander van Akkooi, David W Ollila, Jill Frank, Yun Song, Giorgos Karakousis, et al.

Journal article  |  2021  |  CANCER

BACKGROUND: For patients with sentinel lymph node (SLN)-positive cutaneous melanoma, the Second Multicenter Selective Lymphadenect..

Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis

Kristy K Broman, Tasha M Hughes, Lesly A Dossett, James Sun, Michael J Carr, Dennis A Kirichenko, Avinash Sharma, Edmund K Bartlett, Amanda AG Nijhuis, John F Thompson, Tina J Hieken, Lisa Kottschade, Jennifer Downs, David E Gyorki, J Jennifer Gyorki, Emma Stahlie, Alexander van Akkooi, David W Ollila, Jill Frank, Yun Song, et al.

Journal article  |  2021  |  JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

BACKGROUND: In sentinel lymph node (SLN)-positive melanoma, two randomized trials demonstrated equivalent melanoma-specific surviv..